<SEC-DOCUMENT>0001213900-26-030193.txt : 20260318
<SEC-HEADER>0001213900-26-030193.hdr.sgml : 20260318
<ACCEPTANCE-DATETIME>20260318102230
ACCESSION NUMBER:		0001213900-26-030193
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260318
FILED AS OF DATE:		20260318
DATE AS OF CHANGE:		20260318

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Lask Alisa
		CENTRAL INDEX KEY:			0001767593
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38370
		FILM NUMBER:		26766535

	MAIL ADDRESS:	
		STREET 1:		C/O 380 LACKAWANNA PLACE
		CITY:			SOUTH ORANGE
		STATE:			NJ
		ZIP:			07079

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CollPlant Biotechnologies Ltd
		CENTRAL INDEX KEY:			0001631487
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		4 OPPENHEIMER ST., 11TH FLOOR
		CITY:			REHOVOT
		STATE:			L3
		ZIP:			74140
		BUSINESS PHONE:		972-73-232-5600

	MAIL ADDRESS:	
		STREET 1:		4 OPPENHEIMER ST., 11TH FLOOR
		CITY:			REHOVOT
		STATE:			L3
		ZIP:			74140

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CollPlant Holdings Ltd.
		DATE OF NAME CHANGE:	20190620

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CollPlant Biotechnologies Ltd.
		DATE OF NAME CHANGE:	20190619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CollPlant Holdings Ltd.
		DATE OF NAME CHANGE:	20150122
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0607</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2026-03-18</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001631487</issuerCik>
        <issuerName>CollPlant Biotechnologies Ltd</issuerName>
        <issuerTradingSymbol>CLGN</issuerTradingSymbol>
        <issuerForeignTradingSymbol></issuerForeignTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001767593</rptOwnerCik>
            <rptOwnerName>Lask Alisa</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O COLLPLANT BIOTECHNOLOGIES LTD.</rptOwnerStreet1>
            <rptOwnerStreet2>4 OPPENHEIMER ST, WEIZMANN SCIENCE PARK</rptOwnerStreet2>
            <rptOwnerCity>REHOVOT</rptOwnerCity>
            <rptOwnerState></rptOwnerState>
            <rptOwnerZipCode>7670104</rptOwnerZipCode>
            <rptOwnerStateDescription>ISRAEL</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Restricted Share Units</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>10000</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Options to Purchase Ordinary Shares</value>
                <footnoteId id="F2"/>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>6.39</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2023-05-02</value>
            </exerciseDate>
            <expirationDate>
                <value>2032-05-02</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Ordinary Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>47000</value>
                    <footnoteId id="F2"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Of the restricted share units reported herein, 3,125 units are vested, and the remaining 6,875 units vest in eleven equal quarterly installments beginning March 25, 2026 and ending September 25, 2028, subject to the Reporting Person's continued service to the Issuer as of such vesting date.</footnote>
        <footnote id="F2">44,062 options are fully vested and exercisable and the remaining 2,938 vest is May 2, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Alisa Lask</signatureName>
        <signatureDate>2026-03-18</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
